1.17. Analysis.
Comparison 1 Fluvoxamine versus TCAs, Outcome 17 Subgroup analysis ‐ Response (acute phase) 1. Fluvoxamine dosing ‐ High dosage.
Comparison 1 Fluvoxamine versus TCAs, Outcome 17 Subgroup analysis ‐ Response (acute phase) 1. Fluvoxamine dosing ‐ High dosage.